EKOS Corporation

company

About

EKOS Corporation provides a system for the treatment of vascular thrombosis.

  • 251 - 500

Details

Last Funding Type
Series C
Last Funding Money Raised
$26M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 1995
Number Of Employee
251 - 500
Operating Status
Active

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$44M
EKOS Corporation has raised a total of $44M in funding over 2 rounds. Their latest funding was raised on Mar 21, 2006 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 21, 2006 Series C $26M 1 Detail
Feb 18, 2005 Series B $18M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
EKOS Corporation is funded by 1 investors. EGS Healthcare Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
EGS Healthcare Capital Partners Series C